,,iv  #aae? ,,congress  #a/ ,session    
,h4 ,,res4 #adh  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,febru>y #ag1         
#bjag,mr4 ,higg9s ( ,new ,york submitt$ 
! foll[+ resolution2 :i* 0 ref]r$ to !  
,committee on ,ov]sight & ,gov]nm5t     
,re=m  ,,resolution  ,express+ support =
 ! designation ( ,national ,multiple    
,myeloma ,aw>5ess ,mon?4  ,:]eas        
multiple myeloma 7or myeloma7 is a canc]
 ( plasma cells 9 ! bone m>r[ & is call$
 multiple because ! canc] c occur at    
v>i\s sites 9 ! body2 ,:]eas multiple   
myeloma causes a v>iety ( adv]se heal?  
effects1 includ+ a weak5$ immune sy/em1 
anemia1 kidney damage1 & bone           
det]ioration2 ,:]eas multiple myeloma is
 ! second mo/ common blood canc]        
worldwide2 ,:]eas multiple myeloma      
curr5tly affects m ?an #ajj1jjj p 9 !   
,unit$ ,/ates1 ) ab\t #cj1ccj new       
diagnoses & #ab1fej dea?s f ! disease   
occurr+ 9 #bjaf1 accord+ to !           
,surveillance1 ,epidemiology1 & ,end    
,results ,program ( ! ,national ,canc]  

,in/itute2 ,:]eas al?\gh multiple       
myeloma has be5 & cont9ues to be mo/    
frequ5tly diagnos$ among ^? #fe & ov]1 !
 disease is increas+ly be+ diagnos$ 9   
y\ng] individuals1 includ+ ^? 9 _! #cjs1
 #djs & #ejs2 ,:]eas multiple myeloma is
 almo/ twice z likely to occur among    
,african-,am]icans & is "o ( ! lead+    
causes ( canc] dea?s among              
,african-,am]icans1 ) sci5tific und]/&+ 
( ! disp>ity rema9+ unkn[n2 ,:]eas      
al?\gh ! cause ( multiple myeloma rema9s
 unkn[n1 robu/ rese>* is be+ p]=m$ 9 !  
,unit$ ,/ates & int]nationally into     
pot5tial g5etic1 environm5tal1 & o!r    
risk factors2 ,:]eas additional new     
drugs & !rapies are 9 ! rese>* phase1 ) 
pati5t enrollm5t 9 cl9ical trials play+ 
an important role 9 det]m9+ safe &      
effective treatm5ts2 ,:]eas und]/&+ &   
treatm5t ( multiple myeloma has be5     
greatly fur!r$ by advocacy initiatives  
promot+ aw>5ess1 education1 rese>*1 pe] 
review1 & collaboration & su* ef=ts are 
to be highly comm5d$2 ,:]eas great]     

aw>5ess ( multiple myeloma among        
cl9icians & ! public c lead to e>li]    
detection & treatm5t1 improv+ heal?     
outcomes & br++ com=t to pati5ts & _!   
families2 & ,:]eas ,m>* w\ld be an      
appropriate mon? to designate z         
,national ,multiple ,myeloma ,aw>5ess   
,mon?3 ,n[1 !re=e1 be x ,t ! ,h\se (    
,repres5tatives supports ! designation (
 ,national ,multiple ,myeloma ,aw>5ess  
,mon? to increase public k ( ! disease &
 advance ! vision ( f9d+ a cure =       
multiple myeloma4